Canada’s new drug and biosimilar patent linkage system will fundamentally change the nature of proceedings. J Bradley White and Nathaniel Lipkus of Osler Hoskin & Harcourt discuss key changes of interest to life sciences companies
Michael Loney and Natalie Rahhal analyse five IP decisions issued in Canada, two from the Supreme Court and three from the Federal Court
The landscape for IP litigation has improved considerably in Canada. Kevin P Siu and Steven B Garland of Smart & Biggar
outline the benefits for global rights owners
RT @titorendas: CJEU judgment in Louboutin red sole case to be delivered on June 12. Will the Court follow AG Szpunar's Opinion (available…
RT @ChrisCarani: Apple awarded $533m for design infrgment and $5m for utility infrgment. 2 certainties: appeal and more attention to design…
RT @stshank: Here's the jury verdict: https://t.co/UTwAoZW0LO
Technology alters the anti-counterfeiting landscape
Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International